Skip to content
CancerIndex

Loading the knowledge graph…

A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED) — knowledge graph · CancerIndex